Results 101 to 110 of about 1,527,893 (148)
001 The Use of Tocilizumab in a Case of Biologic-Refractory Antisynthetase Syndrome
, 2016 Antisynthetase syndrome (ASS) is a connective tissue disease consisting of myositis, interstitial lung disease, arthritis, Raynaud’s phenomenon, mechanics’ hands and serum anti-aminoacyl-tRNA synthetase antibodies.
Chinoy, Hector; id_orcid +5 more
core +1 more source
Antisynthetase Syndrome and Autoantibodies: A Literature Review and Report of 4 Cases
, 2019 BACKGROUND With the advent and advancement of autoantibodies, there has been progress in the diagnosis, prognosis, and treatment of rheumatologic diseases.
Marin, Flávia Luiza [UNESP] +1 more
core +1 more source
NELL-1 positive membranous nephropathy in association with antisynthetase syndrome [PDF]
Membranous nephropathy (MN) is an important cause of nephrotic syndrome and is associated with significant adverse health outcomes including progression to end-stage kidney disease, complications relating to volume overload and increased risk of venous ...
Mathavakkannan, Suresh +3 more
core
Anti-synthetase syndrome masquerading as COVID-19
Indian Journal of Rheumatology, 2022 Rajat Kharbanda +2 more
doaj +1 more source
The clinical phenotype associated with antisynthetase autoantibodies
Rheumatology, 2020 Anna Masiak +3 more
doaj +1 more source
Mechanic’s hands lesions in antisynthetase syndrome [PDF]
QJM: An International Journal of Medicine, 2017 V, Mohan, A, Maiti, S V, Cherian
openaire +2 more sources
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course [PDF]
Journal of Clinical Medicine, 2019 Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung disease (ILD), along with specific autoantibodies that are addressed ...
Giovanni Zanframundo +2 more
exaly +7 more sources
Efficacy of Rituximab in Refractory Antisynthetase Syndrome
Internal Medicine Journal, 2012 We report the successful use of repeated administration of rituximab in a patient with antisynthetase syndrome refractory to conventional immunosuppressive medications.
P Hissaria, V Limaye, C -L Liew
exaly +2 more sources